| Tipo : |
Periódico |
| Enlace : |
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4750 |
|
| Los equipos de investigación : |
Sydney - National Institute of Complementary Medicine, Western Sydney University |
| Autores : |
Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J. |
| Título : |
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets. |
| Número : |
Int J Pharm Compound ;24,1:77-82 2020 |
|
| Nivel de evidencia : |
|
| La estabilidad física : |
|
| Estabilidad química : |
|
| Otros métodos : |
|
| Comentarios : |
|
Lista de la molécula
 Metronidazole
|
 |
 |
 |
 |
3000 mg
Metrogyl® |
|
25°C |
 |
| 90 |
 |
|
|
|
|
|
3000 mg
Metrogyl® |
|
25°C |
|
| 90 |
|
|
|
|
|
 |
3000 mg
® = ? |
|
25°C |
|
| 90 |
|
|
|
|
|
|
3000 mg
® = ? |
|
25°C |
|
| 90 |
|
|
|
|
|
|
3000 mg
Metrogyl® |
|
4°C |
|
| 90 |
|
|
|
|
|
|
3000 mg
Metrogyl® |
|
4°C |
|
| 90 |
|
|
|
|
|
|
3000 mg
® = ? |
|
4°C |
|
| 90 |
|
|
|
|
|
|
3000 mg
® = ? |
|
4°C |
|
| 90 |
|
|
|
|
 |
|
150 mg
Metrogyl® |
|
25°C |
|
| 90 |
|
|
|
|
|
|
150 mg
Metrogyl® |
|
25°C |
|
| 90 |
|
|
|
|
|
|
150 mg
® = ? |
|
25°C |
|
| 90 |
|
|
|
|
|
|
150 mg
Metrogyl® |
|
4°C |
|
| 90 |
|
|
|
|
|
|
150 mg
® = ? |
|
4°C |
|
| 90 |
|
|
|
|
|
|
150 mg
Metrogyl® |
|
4°C |
|
| 90 |
|
|
|
|
|
